Rheumatoid arthritis Rheumatoid arthritis Medication adherence
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Male or female subjects who are ≥18 years of age, on the day of signing informed consent. 2) Have a diagnosis of RA (2010 ACR/EULAR criteria for RA) 3) Low or moderate disease activity score (DAS28 2.6-5.1) 4) Ongoing treatment with a stable dose of DMARDs for at least 4 weeks
Exclusion criteria
Exclusion criteria: 1) Have any chronic, uncontrolled medical condition, which would put the subject at increased risk during study participation. 2) High disease activity 3) Have any adverse effect of DMARDs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication adherence 12 weeks Pill count | — |
Secondary
| Measure | Time frame |
|---|---|
| Effect of adherence on disease activity 12 weeks DAS28 | — |
Countries
THAILAND
Contacts
Phramongkutklao Hospital